These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 129285)

  • 1. Mastocytoma-medicated suppression of mixed lymphocyte culture and mitogen responsiveness.
    DeLustro F; Argyris BF
    Cell Immunol; 1976 Jan; 21(1):177-84. PubMed ID: 129285
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in the effects of adult thymectomy on T-cell mediated responses in vitro.
    Andersson LC; Häyry P; Bach MA; Bach JF
    Nature; 1974 Nov; 252(5480):252-4. PubMed ID: 4278652
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunologic unresponsiveness of mouse spleen sensitized to allogenic tumors.
    Argyris BF; DeLustro F
    Cell Immunol; 1977 Feb; 28(2):390-403. PubMed ID: 139208
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of cell-free murine liver extract on lymphocyte blastogenesis in vitro.
    Adler AJ; Kong AS; Friedman EA
    Cell Immunol; 1978 Mar; 36(2):271-82. PubMed ID: 147138
    [No Abstract]   [Full Text] [Related]  

  • 5. The differentiation of suppressor cell populations as revealed by studies of the effects of mitogens on the mixed lymphocyte reaction and on the generation of cytotoxic lymphocytes.
    Ozato K; Ebert JD; Adler WH
    Cell Immunol; 1976 Mar; 22(2):323-33. PubMed ID: 132276
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of mastocytoma-mediated suppression of lymphocyte reactivity.
    DeLustro F; Argyris BF
    J Immunol; 1976 Dec; 117(6):2073-80. PubMed ID: 136473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Humoral mechanisms of in vitro inhibition of mouse lymphocyte immunoreactivity by mastocytoma P815 cells].
    Medvedev AE
    Biull Eksp Biol Med; 1988 Jun; 105(6):701-3. PubMed ID: 2968820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allograft immunity in vitro. V. Generation of cytotoxic effector cells in mixed lymphocyte culture and the specificity of target cell lysis.
    Andersson LC; Häyry P
    Cell Immunol; 1973 Sep; 8(3):470-83. PubMed ID: 4269401
    [No Abstract]   [Full Text] [Related]  

  • 9. Arming of macrophages with lymphocytes from mice immunized with tumor tissue.
    Horowitz M; Argyris BF
    Immunol Commun; 1977; 6(3):297-319. PubMed ID: 69610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of cell-mediated immunity to challenge with P 815 mastocytoma in concanavalin A-treated mice.
    Ekstedt RD; Merdian DJ
    Cell Immunol; 1983 Jan; 75(1):181-7. PubMed ID: 6297806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of the suppression of mitogen responsiveness and the mixed lymphocyte reaction with the proliferative response to viral antigen of splenic lymphocytes from cytomegalovirus-infected mice.
    Kelsey DK; Overall JC; Glasgow LA
    J Immunol; 1978 Aug; 121(2):464-70. PubMed ID: 210231
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells.
    Peavy DL; Pierce CW
    J Exp Med; 1974 Aug; 140(2):356-69. PubMed ID: 4276949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat-mouse xenogeneic proliferative and cytolytic phases assay: attempt for a genetic survey.
    Charpentier B; Lang P; Houssin D; Martin B; Fries D
    Transplant Proc; 1981 Jun; 13(2):1476-80. PubMed ID: 6454291
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of concanavalin A treatment on the allogeneic response of mice to challenge with P 815 mastocytoma: interleukin 2 treatment reverses concanavalin A suppression in vivo.
    Ekstedt RD; Merdian DJ
    Cell Immunol; 1984 May; 85(2):447-58. PubMed ID: 6424952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression induced in vitro by mastocytoma tumor cells and cell-free extracts.
    Kamo I; Patel C; Kateley J; Friedman H
    J Immunol; 1975 Jun; 114(6):1749-56. PubMed ID: 805176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of lymphocyte signal transduction by murine mastocytoma ascites.
    Ding L; Isobe K; Yoshida T; Nakashima I
    Microbiol Immunol; 1991; 35(9):767-74. PubMed ID: 1808472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor cells in the spleen of tumor-allosensitized mice.
    Argyris BF
    Cancer Res; 1977 Sep; 37(9):3390-9. PubMed ID: 141979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells in mixed-lymphocyte-culture-induced cytolysis (MLC-CML).
    Häyry P; Andersson LC
    Transplant Proc; 1973 Dec; 5(4):1697-703. PubMed ID: 4272824
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult thymectomy results in loss of T-dependent mitogen response in mouse spleen cells.
    Jacobs DM; Byrd W
    Nature; 1975 May; 255(5504):153-5. PubMed ID: 1093041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.